Occult HBV infection may negatively impact on drug survival in patients with rheumatoid arthritis on treatment with a first biologic drug. An appraisal from the Biologic Apulian Registry (BIOPURE). Reumatismo [Internet]. 2019 Apr. 1 [cited 2025 Jun. 27];71(1):24-30. Available from: https://www.reumatismo.org/reuma/article/view/1154